Leeds software firm Envoke has set its sights on the Asia-Pacific market after securing an additional £1.6 million in funding. The company, which provides remote training and support for medical professionals through its innovative platform, has raised the capital from existing and new investors.
Funding Details
The investment comes from existing backers NPIF – Mercia Equity Finance, managed by Mercia and part of the Northern Powerhouse Investment Fund, and Finance Yorkshire’s Seedcorn Fund, alongside new investor Foresight Group. This latest injection brings the total funds raised by Envoke to over £4 million.
Company Growth and Clients
Founded in 2019 by Stuart Warrington, Envoke has recently won several major clients, including Hawaii’s national blood laboratories and the US-based Mayo Clinic. The company is on track to exceed £1 million in annual recurring revenue within the next 12 months. It has also attracted major US equipment manufacturers such as Bio-Rad, ThermoFisher Scientific, PacBio, and Haemonetics, as well as the NHS and other health services and universities.
Technology Impact
Envoke’s platform creates a virtual replica of complex laboratory equipment and uses interactive simulations to train staff. The system also enables remote troubleshooting and maintenance, reducing the need for engineer call-outs by 15-20%. This helps manufacturers cut servicing costs and allows healthcare providers to avoid service disruptions caused by breakdowns.
Employment and Future Plans
The company currently employs 16 staff, including two in the US, and expects to create three to five new jobs in the UK over the next year. With the new funding, Envoke aims to target a wider global audience, particularly in the Asia-Pacific region.
CEO Statement
Stuart Warrington, CEO of Envoke, said: “Laboratory equipment is challenging to operate and technical problems are commonplace. Each service call-out typically costs manufacturers $2,500 and a breakdown can seriously disrupt health services by delaying critical test results. Envoke is tackling these problems. Customer feedback shows our system helps laboratories to reduce downtime and provide more consistent operator training, while enabling manufacturers to cut service costs and boost revenue.”
Investor Comments
Dawn Tyler of Mercia Ventures commented: “Envoke has come a long way since our original investment three years ago. The company has built an impressive client base among US multinationals, achieved very positive customer feedback and launched a new platform that is the most powerful to date. With growing global demand for virtual training and maintenance systems, it is now well positioned to reach out to an even wider international audience.”
Finance Yorkshire CEO Alex McWhirter added: “Envoke is a trailblazer in the health care technology sector with its solutions attracting a worldwide customer base. Finance Yorkshire is pleased to support the company in its next stage of growth and ambition to compete in the Asia-Pacific market.”
Line Gauteplass, Senior Investment Manager at Foresight Group, said: “Envoke has developed a highly compelling platform that addresses real operational challenges for both laboratory equipment manufacturers and healthcare providers. The business has already demonstrated strong traction with leading global customers, and we see significant potential as it expands internationally, particularly across Asia‑Pacific. We are pleased to support Stuart and the team as they scale the business and build on this next phase of growth.”
Debbie Sorby, Senior Investment Manager at the British Business Bank, said: “It is encouraging to see the Northern Powerhouse Investment Fund continuing to support Envoke as it advances through its growth journey, illustrating how the fund enables businesses to scale over time. The company has made strong progress to date, establishing a robust customer base and delivering technology that addresses well‑defined challenges in laboratory training and maintenance.”
